Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 282 publications
Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 28, 2026
Standardized numbering and alignment of the KPC family of β-lactamases.
Journal: Antimicrobial agents and chemotherapy
Published: May 29, 2026
Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat Pseudomonas aeruginosa clinical isolates.
Journal: JAC-antimicrobial resistance
Published: April 02, 2026
Comparative in vitro activity of aztreonam-avibactam and aztreonam plus ceftazidime-avibactam against Stenotrophomonas maltophilia complex.
Journal: Antimicrobial agents and chemotherapy
Published: March 24, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infections.
Journal: Antimicrobial agents and chemotherapy
Published: March 23, 2026
A Clinical Case of Treatment-Emergent Acinetobacter baumannii Non-Susceptibility to Sulbactam-Durlobactam.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 22, 2026
A comparative evaluation of aztreonam-avibactam and ceftazidime-avibactam plus aztreonam for infections due to MBL-producing Enterobacterales.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 02, 2026
Aminoglycosides enhance meropenem/vaborbactam activity against KPC-producing Klebsiella pneumoniae in the hollow fiber infection model.
Journal: Antimicrobial agents and chemotherapy
Published: February 19, 2026
Activity of novel antibiotics against dual metallo-Beta-lactamase producing Enterobacter hormaechei clinical isolates.
Journal: JAC-antimicrobial resistance
Published: January 23, 2026
Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections.
Journal: Open forum infectious diseases
Published: September 02, 2025
Escherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 07, 2025
Do Aminopenicillins Have a Role in Treating Ampicillin-Resistant Enterococcus UTIs?
Journal: Open forum infectious diseases
Published: July 11, 2025
Last Updated: 09/26/2026